{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:52:38Z","timestamp":1747162358362,"version":"3.40.5"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T00:00:00Z","timestamp":1719705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ijid.2024.107163","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T21:45:21Z","timestamp":1720043121000},"page":"107163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["COVID-19 in patients with haematologic malignancies: Effect of RNAemia on clinical outcome in vaccinated patients"],"prefix":"10.1016","volume":"146","author":[{"given":"Javier","family":"Mart\u00edn-Escolano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonsoles","family":"Salto-Alejandre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Infante-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Carretero-Ledesma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Maldonado-Lizarazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Camacho-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Mart\u00edn-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Tall\u00f3n-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Ruiz-Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaira","family":"Palacios-Baena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3775-5330","authenticated-orcid":false,"given":"Patricia","family":"P\u00e9rez-Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3156-7512","authenticated-orcid":false,"given":"Mar\u00eda","family":"Paniagua-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"\u00c1lvarez-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5001-672X","authenticated-orcid":false,"given":"Jos\u00e9 Miguel","family":"Cisneros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7766-7266","authenticated-orcid":false,"given":"Elisa","family":"Cordero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8166-5308","authenticated-orcid":false,"given":"Jer\u00f3nimo","family":"Pach\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"P\u00e9rez-Sim\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"S\u00e1nchez-C\u00e9spedes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Aguilar-Guisado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijid.2024.107163_bib0001","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/jamaoncol.2021.5148","article-title":"Evaluation of COVID-19 mortality and adverse outcomes in US patients with or without cancer","volume":"8","author":"Chavez-MacGregor","year":"2022","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.ijid.2024.107163_bib0002","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1038\/s41375-021-01302-5","article-title":"COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey","volume":"35","author":"Ljungman","year":"2021","journal-title":"Leukemia"},{"issue":"14","key":"10.1016\/j.ijid.2024.107163_bib0003","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1182\/blood.2021012769","article-title":"Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy","volume":"138","author":"Dhakal","year":"2021","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ijid.2024.107163_bib0004","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/jmv.26404","article-title":"The outcome of COVID-19 in patients with hematological malignancy","volume":"93","author":"Yigenoglu","year":"2021","journal-title":"J Med Virol"},{"issue":"5","key":"10.1016\/j.ijid.2024.107163_bib0005","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/ejh.13493","article-title":"Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies","volume":"105","author":"Sanchez-Pina","year":"2020","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.ijid.2024.107163_bib0006","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1111\/bjh.16935","article-title":"Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience","volume":"190","author":"Shah","year":"2020","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.ijid.2024.107163_bib0007","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.0130","article-title":"Mortality among adults with cancer undergoing chemotherapy or immunotherapy and infected with COVID-19","volume":"5","author":"V\u00e1rnai","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.ijid.2024.107163_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100499","article-title":"COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE)","volume":"7","author":"Castelo-Branco","year":"2022","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.ijid.2024.107163_bib0009","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13045-021-01177-0","article-title":"COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)","volume":"14","author":"Pagano","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.ijid.2024.107163_bib0010","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12889-024-17790-w","article-title":"Association between vaccination rates and COVID-19 health outcomes in the United States: a population-level statistical analysis","volume":"24","author":"Du","year":"2024","journal-title":"BMC Public Health"},{"issue":"10","key":"10.1016\/j.ijid.2024.107163_bib0011","doi-asserted-by":"crossref","first-page":"e737","DOI":"10.1016\/S2352-3026(20)30251-9","article-title":"Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study","volume":"7","author":"Passamonti","year":"2020","journal-title":"Lancet Haematol"},{"issue":"23","key":"10.1016\/j.ijid.2024.107163_bib0012","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1002\/cncr.33160","article-title":"Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19","volume":"126","author":"Cattaneo","year":"2020","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ijid.2024.107163_bib0013","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/ejh.13977","article-title":"Risk factors and outcomes of COVID-19 in adult patients with hematological malignancies: a single-center study showing lower than expected rates of hospitalization and mortality","volume":"111","author":"Aumann","year":"2023","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.ijid.2024.107163_bib0014","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13045-020-00970-7","article-title":"Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study","volume":"13","author":"Garc\u00eda-Su\u00e1rez","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.ijid.2024.107163_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00277-021-04644-3","article-title":"Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India","volume":"101","author":"Gupta","year":"2022","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.ijid.2024.107163_bib0016","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/S2352-3026(20)30429-4","article-title":"Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study","volume":"8","author":"Sharma","year":"2021","journal-title":"Lancet Haematol"},{"issue":"1","key":"10.1016\/j.ijid.2024.107163_bib0017","doi-asserted-by":"crossref","first-page":"13134","DOI":"10.1038\/s41598-021-92497-1","article-title":"Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients","volume":"11","author":"Rodr\u00edguez-Serrano","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ijid.2024.107163_bib0018","doi-asserted-by":"crossref","first-page":"7163","DOI":"10.1038\/s41598-021-86500-y","article-title":"The impact of viremia on organ failure, biomarkers and mortality in a Swedish cohort of critically ill COVID-19 patients","volume":"11","author":"J\u00e4rhult","year":"2021","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.ijid.2024.107163_bib0019","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3390\/v12091045","article-title":"RNAemia corresponds to disease severity and antibody response in hospitalized COVID-19 patients","volume":"12","author":"Eberhardt","year":"2020","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ijid.2024.107163_bib0020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12879-021-05886-2","article-title":"SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study","volume":"21","author":"Colagrossi","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"7","key":"10.1016\/j.ijid.2024.107163_bib0021","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.3390\/v15071560","article-title":"SARS-CoV-2 RNAemia and disease severity in COVID-19 patients","volume":"15","author":"Lawrence-Panchali","year":"2023","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.ijid.2024.107163_bib0022","doi-asserted-by":"crossref","first-page":"465","DOI":"10.23736\/S0031-0808.22.04705-X","article-title":"Baseline plasma SARS-CoV-2 RNA detection predicts an adverse COVID-19 evolution in moderate to severe hospitalized patients","volume":"64","author":"Rizzi","year":"2022","journal-title":"Panminerva Med"},{"issue":"5","key":"10.1016\/j.ijid.2024.107163_bib0023","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jinf.2023.01.019","article-title":"Serum IFN-\u03b3 and RNAemia temporal profiles as biomarkers of severe COVID-19 in solid organ transplant and immunocompetent patients","volume":"86","author":"Salto-Alejandre","year":"2023","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.ijid.2024.107163_bib0024","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.ijid.2024.107163_bib0025","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijid.2020.06.038","article-title":"Performance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with COVID-19","volume":"98","author":"Satici","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2024.107163_bib0026","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jinf.2020.09.023","article-title":"A quick prediction tool for unfavourable outcome in COVID-19 inpatients: development and internal validation","volume":"82","author":"Salto-Alejandre","year":"2021","journal-title":"J Infect"},{"issue":"7","key":"10.1016\/j.ijid.2024.107163_bib0027","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1007\/s00330-023-09427-0","article-title":"Association of subpleural ground-glass opacities with respiratory failure and RNAemia in COVID-19","volume":"33","author":"Nagaoka","year":"2023","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.ijid.2024.107163_bib0028","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s15010-022-01869-w","article-title":"Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study","volume":"50","author":"Oliva","year":"2022","journal-title":"Infection"},{"issue":"7","key":"10.1016\/j.ijid.2024.107163_bib0029","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41591-021-01386-7","article-title":"CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer","volume":"27","author":"Bange","year":"2021","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.ijid.2024.107163_bib0030","doi-asserted-by":"crossref","first-page":"100788","DOI":"10.1016\/j.trre.2023.100788","volume":"37","author":"Herrera","year":"2023","journal-title":"Transplant Rev (Orlando)"},{"issue":"3","key":"10.1016\/j.ijid.2024.107163_bib0031","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/bjh.17704","article-title":"COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies","volume":"195","author":"Passamonti","year":"2021","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.ijid.2024.107163_bib0032","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41408-022-00608-6","article-title":"Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients","volume":"12","author":"Borgogna","year":"2022","journal-title":"Blood Cancer J"},{"issue":"9","key":"10.1016\/j.ijid.2024.107163_bib0033","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41408-021-00546-9","article-title":"Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab","volume":"11","author":"Cattaneo","year":"2021","journal-title":"Blood Cancer J"},{"issue":"3","key":"10.1016\/j.ijid.2024.107163_bib0034","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1016\/j.jinf.2020.11.024","article-title":"SARS-CoV-2 RNAemia is associated with severe chronic underlying diseases but not with nasopharyngeal viral load","volume":"82","author":"Berastegui-Cabrera","year":"2021","journal-title":"J Infect"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224002340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224002340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T01:33:43Z","timestamp":1723167223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971224002340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":34,"alternative-id":["S1201971224002340"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107163","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 in patients with haematologic malignancies: Effect of RNAemia on clinical outcome in vaccinated patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107163"}}